Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-08-03
1992-02-18
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
540461, 548433, A01N 4390, C07D48702
Patent
active
050895176
ABSTRACT:
A method for reducing adverse effects of neurotoxic injury, which comprises administering to a patient susceptible to neurotoxic injury an effective amount, sufficient to reduce the injury, of a compound having an indolactam V ring system. Particularly preferred are compounds having ring stereochemistry as indicated in the following formula: ##STR1## The indicated substituents show preferred locations of substituents; preferred substituents are defined in the specification.
REFERENCES:
Nakatsuka et al. Tetrahedran Lett. (1987) 28: 2265-2268.
Maritaki et al. Tetrahedron Lett. (1988) 29: 6267-6270.
Okabe et al. Chem. Pharm. Bull. (1989) 37: 563-564.
Rothman, S., "Synaptic Release of Excitatory Amino Acid Neurotransmitter Mediates Anoxic Neuronal Death", J. Neurosci. (1984) 4:1884-1891).
Simon, R. P. et al., "Blockade of N-Methyl-B-Aspartate Receptors May Protect Against Ischemic Damage in the Brain", Science (1984) 226:850-852).
Weiloch, T., "Hypoglycemia-Induced Neuronal Damage Prevented by an N-Methyl-D-Aspartate Antagonist", Science (1985) 230:681-683.
Choi, D., "Glutamate Neurotoxicity and Diseases of the Nervous System" Neuron (1988) 1:623-634.
Harata et al., Bull. Chem. Soc. Japan (1966) 39:1773-1775.
Irie et al., Int. J. Cancer (1985) 36:485-488.
Fujiki et al., Proc. Japan Acad., Ser. D, (1985) 61:45-47.
Horiuchi et al., Gann. (1984) 75:837-840.
Irie and Coshimizu, Mem. Coll. Agric., Kyoto Univ., (1988) 132:1-59.
Jan. 1990 New Products Bulletin of L. C. Services Corporation, Woburn, Mass.
Choi Dennis W.
Hartley Dean M.
Burn Brian M.
Hollrah Glennon H.
The Board of Trustees of the Leland Stanford Junior University
LandOfFree
Neuroprotection by indolactam V and derivatives thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neuroprotection by indolactam V and derivatives thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neuroprotection by indolactam V and derivatives thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1823893